Atea Pharmaceuticals (AVIR) Non-cash Items (2019 - 2026)

Atea Pharmaceuticals' Non-cash Items history runs 8 years deep, the most recent figure standing at $26.6 million for Q1 2026.

• In Q1 2026, Non-cash Items rose 444.85% year-over-year to $26.6 million; the TTM figure through Mar 2026 stood at $26.6 million (up 444.85% YoY), while the FY2025 annual figure was $8.4 million, up 38.41% from the prior year.
• Non-cash Items was $26.6 million for Q1 2026 at Atea Pharmaceuticals, up from $8.4 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $26.6 million in Q1 2026 to a low of $6070.0 in Q1 2023.
• Historically, Non-cash Items has averaged $7.2 million across 5 years, with a median of $6.0 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Non-cash Items tumbled 64.99% in 2022, then jumped 140954.37% in 2024.
• A 5-year view of Non-cash Items shows it stood at $10.9 million in 2022, then slumped by 53.55% to $5.1 million in 2023, then climbed by 19.98% to $6.1 million in 2024, then jumped by 38.41% to $8.4 million in 2025, then jumped by 215.24% to $26.6 million in 2026.
• The last three Non-cash Items figures came in at $26.6 million (Q1 2026), $8.4 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.